L3Harris (LHX)
NYSEIndustrialsAerospace & DefenseSnapshot 2026-11-05
$258.11-0.63%
Close 2026-11-05 · 1-day change
NYSEIndustrialsAerospace & DefenseSnapshot 2026-11-05
Research Workspace
Put LHX beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Aerospace & Defense is in expansion. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisRevenue is growing steadily — about 7% over the past year.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityManagement screens strong on earnings delivery, margins.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskMostly healthy — no soft spokes
LHX's defense backlog has to keep compounding to justify the price. Revenue growth is slowing, dropping from 12% to 7% year over year. The company beat its Q3 earnings estimate by 9.3%. It trades at 21 times earnings, below the 29 times peer median. The price reflects less growth than we forecast. A fraud investigation threatens the operating margin. Peer multiples imply a price about 26% above where it trades. Our read remains intact. This read is provisional.
End-of-day figures as of 2026-11-05. EPS is implied from price ÷ P/E. Not investment advice.
Trailing returns as of 2026-11-05. LHX is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 23 analysts currently covering LHX (as of Nov 2026).
Based on 4 Wall Street analysts offering 12-month price targets for LHX in the last 4 months.
Current $258.11
The last 12 months of price, then the range of analyst 12-month targets from today’s $258.11.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
Continue this research
Compare LHX with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| LHX Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 12 valuation methods, at three horizons. As of 2026-11-05. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Above average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
A price-focused, side-by-side fair-value read versus Aerospace & Defense — fair value, gap to price, and forward P/E.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Compare the value case
Put LHX next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Deliver on financial commitments and 2026 guidance
Reaffirmed 2028 growth and issued 2026 EPS guidance, supporting delivery against financial commitments.
Advances: Increase revenue and grow backlog
New production capacity supports rocket-motor output and backlog growth.
Advances: Increase revenue and grow backlog
Rating upgrade supports revenue growth and backlog increase.
Advances: Increase revenue and grow backlog
Significant contract win enhances revenue and backlog growth.
Fraud investigation could impact revenue and margins.
Threatens: Maintain and improve operating margin
Downgrade indicates potential operational and financial risks.
CEO exit raises concerns about future leadership stability.
Leadership change may disrupt strategic execution and investor confidence.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.